Hotline 24/7: 0909384389

Share links:

CathWorks gains Japanese regulatory approval for FFRangio system

Ngày 15/10/2022 03:10 | Lượt xem: 442

CathWorks has announced approval of the fourth generation CathWorks FFRangio system by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). The FFRangio system is also commercially available in the USA and Europe.

“The FFRangio System enables us to quickly perform a comprehensive physiologic assessment of coronary artery disease without the need for invasive pressure wires or hyperaemic agents, providing significant benefits to clinicians and patients,” said Yutaka Hikichi (Saga-Ken Medical Center Koseikan, Saga, Japan). “The approval of the fourth-generation application offers significant automation and enhancements, further simplifying the utilisation of the platform.”

“Coronary artery disease is a life-threating disease, and it is critical that we can quickly, effectively, and cost-effectively diagnose the disease and determine the appropriate treatment plan,” said Mamoru Nanasato (Sakakibara Heart Institute, Tokyo, Japan). “We have been able to experience first-hand how FFRangio can transform the diagnosis and treatment of our patients with coronary artery disease.”

The CathWorks FFRangio system has been the first non-invasive device of its kind to receive Japan PMDA and Ministry of Health, Labour and Welfare (MHLW) approval for diagnosis of functional ischemia for patients with ischemic coronary artery disease, CathWorks said in a press release. The fourth-generation application includes automation and enhancements, while offering the same diagnostic accuracy when compared to invasive wire-derived FFR, the press release adds.

Source CardiovascularNews

Duc Tin CLinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support